dexmedetomidine nasal spray
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
November 08, 2021
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children
(clinicaltrials.gov)
- P3; N=159; Not yet recruiting; Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Clinical • New P3 trial • Anesthesia
July 15, 2021
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults
(clinicaltrials.gov)
- P2/3; N=201; Active, not recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Recruiting ➔ Active, not recruiting; N=108 ➔ 201; Trial completion date: May 2021 ➔ Sep 2021
Clinical • Enrollment change • Enrollment closed • Trial completion date • Anesthesia
January 06, 2021
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults
(clinicaltrials.gov)
- P2/3; N=108; Recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Trial completion date: Oct 2020 ➔ May 2021; Trial primary completion date: Sep 2020 ➔ May 2021
Clinical • Trial completion date • Trial primary completion date • Anesthesia
September 09, 2020
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children
(clinicaltrials.gov)
- P1; N=48; Completed; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Recruiting ➔ Completed
Clinical • Trial completion • Anesthesia
September 09, 2020
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults
(clinicaltrials.gov)
- P2/3; N=108; Recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Anesthesia
1 to 5
Of
5
Go to page
1